Heath-Chiozzi Margo 4
4 · Celldex Therapeutics, Inc. · Filed Nov 3, 2021
Insider Transaction Report
Form 4
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
Transactions
- Exercise/Conversion
Incentive Stock Option (Right to Buy)
2021-11-01−600→ 42,400 totalExercise: $2.78Exp: 2029-06-19→ Common Stock (600 underlying) - Exercise/Conversion
Common Stock
2021-11-01$2.78/sh+600$1,668→ 11,847 total - Sale
Common Stock
2021-11-01$41.71/sh−600$25,026→ 11,247 total
Footnotes (2)
- [F1]The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021.
- [F2]25 % vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.